WikiJournalClub:Requested articles

Wiki Journal Club readers regularly request articles through the apps. The bot reads each of these emails and tallies the requests, posting the results here. Because the request emails are free-form, sometimes the bot gets it all wrong. You can help the bot by editing the mapping rules. Here are the current requests, ranked by number of times the article has been requested.

• DAWN (27)
• ARRIVE (19)
• INTERACT 2 (9)
• AMBITION (8)
• CESAR (8)
• PATCH (8)
• PROPPR (8)
• STOP-IT (7)
• CATCH (6)
• CHAMPION (6)
• COACT (6)
• REVERT (6)
• UNLOAD (6)
• CADISS (5)
• COMPANION (5)
• CRUSADE (5)
• SEATTLE II (5)
• ANDROMEDA (4)
• BEAUTIFUL (4)
• CHIPS (4)
• CIBIS-II (4)
• CRYSTAL AF (4)
• DEFUSE 3 (4)
• EAGLES (4)
• ISCHEMIA (4)
• MATTERS (4)
• MERINO (4)
• NOBLE (4)
• PATHWAY-2 (4)
• PIVENS (4)
• PRESERVE (4)
• SAVOR TIMI (4)
• SENIORS (4)
• SPICE III (4)
• STOP IT (4)
• SWIFT PRIME (4)
• WOMAN (4)
• Z11 (4)
• A (3)
• ACUITY (3)
• AFIRE (3)
• AIM-HIGH (3)
• ATACH-2 (3)
• CIBIS (3)
• CREDO (3)
• CROSS (3)
• DIAMOND (3)
• DREAM (3)
• ECLIPSE (3)
• EOLIA (3)
• FLORALI (3)
• HARMONY (3)
• HORIZON (3)
• INTERHEART (3)
• IST-3 (3)
• ISUIA (3)
• LEAP (3)
• MAGIC (3)
• MAPEC (3)
• MATRIX (3)
• MEPEX (3)
• MIST2 (3)
• NOTION (3)
• OASIS (3)
• OAT (3)
• OPTIC NEURITIS TREATMENT (3)
• PARAGON-HF (3)
• PERFECT (3)
• PRAISE (3)
• PRECOMBAT (3)
• Paragon-HF (3)
• RE-DUAL PCI (3)
• RELY (3)
• Rewind (3)
• SERAPHIN (3)
• SHARP (3)
• TITRE2 (3)
• VITAL (3)
• WAKE-UP (3)
• [[1]] (3)
• ACCORD LIPID (2)
• AFIRE study (2)
• AIM HIGH (2)
• AMACING (2)
• AMAZES (2)
• APPRAISE-2 (2)
• APROCCHSS (2)
• ARCH (2)
• ARMA (2)
• ARUBA (2)
• ASCOT (2)
• ASSERT (2)
• ATACH 2 (2)
• ATACH II (2)
• AVID (2)
• BLESS (2)
• CALM (2)
• CARES (2)
• CARMELINA (2)
• CLEVER (2)
• COMMANDER HF (2)
• COMPLETE (2)
• CORE (2)
• CRASH-3 (2)
• DAPA HF (2)
• DECLARE-TIMI (2)
• DEFER (2)
• DEFUSE (2)
• DEFUSE AND DAWN (2)
• DEVOTE (2)
• EAGLES STUDY (2)
• ELAIN (2)
• EMANATE (2)
• EVAPORATE (2)
• EVEREST II (2)
• GALA (2)
• GAUSS-3 (2)
• GEMINI (2)
• GRAVITAS (2)
• HAPO (2)
• ICTUS (2)
• INTERACT-2 (2)
• LEAP STUDY (2)
• LOTT (2)
• MADIT RIT (2)
• MEDENOX (2)
• MTOPS (2)
• NEUROPSYCHIATRIC SAFETY AND EFFICACY OF VARENICLINE (2)
• OASIS-6 (2)
• PALLAS (2)
• PARAMEDIC2 (2)
• PAUSE (2)
• PEGASUS TIMI 54 (2)
• PONCHO (2)
• PROACT (2)
• PROACTIVE (2)
• PROCAMIO (2)
• PROSPER (2)
• PROTECT II (2)
• PULMONARY ARTERIAL HYPERTENSION (2)
• Primary Care Physician Perspectives about Antipsychotics and Other Medicatio= (2)
• REDUAL PCI (2)
• REDUCE IT (2)
• REGATTA (2)
• REWIND (2)
• RINSE (2)
• RIVAL (2)
• Rematch= (2)
• SAPPHIRE (2)
• SAVOR AND EXAMINE (2)
• SERVE-HF (2)
• SPLIT (2)
• STREAM (2)
• SURVIVE (2)
• SYGMA (2)
• THE ARRIVE (2)
• TIOSPIR (2)
• TORDIA (2)
• TRACS (2)
• Twilight (2)
• ULTIMA (2)
• VALUE (2)
• WAKEUP (2)
• WARCEF (2)
• WAVE (2)
• Z11 BREAST CANCER (2)
• Intervention for Vesicoureteral Reflux (RIVUR) Study. (1)
• Patel (1)
• to see more (1)
• ( Multicentre Intrapleural Sepsis (1)
• [[.]] (1)
• . Ga= (1)
• . Please excuse any typos. (1)
• 1) Continuous Positive Airway Pressure for central sleep apnea ( CanPAP); NE= (1)
• A Control (1)
• A Comparison of Two LDL Cholesterol (1)
• A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemi= (1)
• A HIGHLY DURABLE RNAI THERAPEUTIC INHIBITOR OF PCSK9 BY FITZGERALD ET AL (1)
• A MULTINATIONAL (1)
• A Multicomponent Intervention to Prevent Delirium in Hospitalized Older Pati= (1)
• A No prophylaxis platelet-transfusion strategy for hematologic cancers (13= (1)
• A Phase 3 (1)
• ABC STUDY (1)
• ABCD2 score= (1)
• ABESTT AND ABESTT 2 (1)
• ABOARD (1)
• ABSORB (1)
• ACAS (1)
• ACAS -ASYMPTOMATIC CAROTID ATHEROSCLEROSIS STUDY (1)
• ACCEPT D (1)
• ACCOAST (1)
• ACHILLES - Comparing Angioplasty and DES in the Treatment of Subjects with I= (1)
• ACIP (1)
• ACME 1992 (1)
• ACST (1)
• ACST-1 (1)
• ACST2 (1)
• ACT1 (1)
• ACUTE (1)
• ACUTE (assessment of cardioversion using transesophageal echocardiography) t= (1)
• ADAM VTE (1)
• ADAM-VTE (1)
• ADAMS TD (1)
• ADAPT (1)
• ADHERE (1)
• ADHERE CART (1)
• ADHERE STUDY (1)
• ADHERE= (1)
• ADISAI IPAD MINI (1)
• ADNVANCE III (1)
• ADONIS TRAIL - AMERICAN AUSTRALIAN (1)
• ADROMEDA SHOCK= (1)
• ADSORB (1)
• ADVANCE-1 (1)
• ADjunctive coRticosteroid trEatment iN criticAlly ilL Patients With Septic S= (1)
• AFIRE NEJM (1)
• AIM HIGH= (1)
• AIM-HIGH (11) (1)
• AIM-HIGH AND HPS2-THRIVE (1)
• AIR VERSUS OXYGEN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (1)
• AIRE (1)
• AJAY JANI (1)
• ALARM HF (1)
• ALCYONE (1)
• ALDO-DHF (1)
• ALEXANDER J (1)
• ALP (1)
• ALVEOLI (1)
• AMAROS (1)
• AMBITION IN PAH (1)
• AMBITION: combination therapy for pulmonary hypertension (1)
• AMBITION= (1)
• AMETHYST-DN (1)
• ANAESTHESIA (1)
• ANDROMEDA FOR DRONEDARONE (1)
• ANDROMEDA SHOCK (1)
• ANDROMEDA= (1)
• ANEURYSM (1)
• ANZICS (1)
• AOST0331 (1)
• APACE (1)
• APACHE 1 (1)
• APPAC. Antibiotic therapy vs. appendectomy (1)
• APROCCHS steroids and fludrocortisone in septic shock. (1)
• AQUAPHERESIS VERSUS IV DIURETICS AND HOSPITALIZATIONS FOR HEART FAILURE (1)
• ARDS (1)
• ARDS NET (1)
• ARE YOU COVERING PAEDIATRICS (1)
• ARIC - USE OF PPIS WITH INCREASED RISK OF CKD (1)
• ARMYDA-2 (1)
• ARRIVE (18) (1)
• ARRIVE ASPIRIN (1)
• ARRIVE STUDY (1)
• ARRIVE= (1)
• ARTIC (1)
• ARTS (1)
• ASAP (1)
• ASAP AND ASSAP-TOO (1)
• ASCEND-HF (1)
• ASCERT= (1)
• ASCOT BP LOWERING (1)
• ASCOT: Anglo Scandinavian Cardiac Outcomes (1)
• ASCOTT (1)
• ASPECT (1)
• ASPECTS (1)
• ASPIRATION THROMBECTOMY (1)
• ASPREE (ASPirin in Reducing Events in the Elderly) (1)
• ASPREE (aspirin in reducing events in the elderly) (1)
• ASPREE ASPIRIN IN REDUCING EVENTS IN THE ELDERLY (1)
• ASSENT 3 (1)
• ASSENT 4 (1)
• ASSERT STUDY (1)
• ASSESSMENT OF CLINICAL CRITERIA FOR SEPSIS (1)
• ASTERIA (1)
• ASTRONAUT (1)
• ASTRONOMER (1)
• ASYNPTOMATIC CAROTID ARTERY STENOSIS (1)
• ATACAS (1)
• ATACH (1)
• ATACH 1 (1)
• ATACH 1 AND 2 (1)
• ATCC (1)
• ATHOS3 (1)
• ATLAS SUR IECA HAUTE OU PETITE DOSE (1)
• ATMOSPHERE (1)
• ATMOSPHERE= (1)
• ATOLL (1)
• ATP4 (1)
• ATTACH 2 (1)
• ATTACH-2 (1)
• AUGUSTUS https://www.nejm.org/doi/full/10.1056/NEJMoa1817083 (1)
• AUGUSTUS!!! Pleasee!!! (1)
• AUSTRI (1)
• AWARD-4 (1)
• AWARD-8 (1)
• AZALEA= (1)
• AZITHROMYCIN FOR PREVENTION OF EXACERBATIONS OF COPD (1)
• AZITHROMYCIN PROPHYLAXIS FOR COPD (1)
• Adjunct prednisone in CAP. Blum et al lancet 4-15. (1)
• Adjuvant ipilimumab versus placebo after resection of high risk stage III me= (1)
• Akiki - NEJM 16. Initial strategies for renal replacement therapy in ICU (1)
• Aldo-DHF spironolactone vs. Placebo in hfpef (1)
• Alisha C. Jetha (1)
• All (1)
• All PFO related: (1)
• All the CIBIS trias!!! Incredible important in the history of beta blockers i= (1)
• Allow notifications for new studies as they are added.= (1)
• Anaesthesia related (1)
• Andromeda Shock Study (1)
• Annexa-4 Full report Feb 19 (1)
• Anything on fibromuscular dysphasia? (1)
• Apronet= (1)
• Aristophanes (1)
• Atach-2 & PATCH (1)
• Augusta (1)
• Augustus in NEJM April 19 (1)
• B AWARE (1)
• B-CONVINCED (1)
• B-Convinced (B-block in acute decompensated HF) (1)
• B-VITAGE out of the British journal of psychiatry. (1)
• BACE (1)
• BACE (COPD (1)
• BAFTA (1)
• BALANCE (1)
• BALANCE and CEQUEL (1)
• BATFA (1)
• BEAM (1)
• BENEFIT - BELATACEPT VS CYCLOSPORINE FOR POST TRANSPLANT IMMUNOSUPPRESSION (1)
• BEST TRIP (1)
• BHAT STUDY (1)
• BISPHOSPHONATES (1)
• BLOCK HF (1)
• BRAIN ICU (1)
• BREATH program. Based on (1)
• BREATHING NOT PROPERLY (1)
• BRUISE -CONTROL 1 (1)
• BRYAN (1)
• Balanced crystallizes vs saline in critical ill adults @NEJM (1)
• Bedtime hypertension treatment improves cardiovascular risk reduction: Hygia= (1)
• Bicar-ICU (Lancet July 18) (1)
• Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With= (1)
• Boost 1 and 2= (1)
• Breathing Not Properly study= (1)
• Bypass vs angioplasty in severe ischemia of the leg (BASIL) from the journal= (1)
• C-Surfer (1)
• CABANA - Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fib= (1)
• CABANA= (1)
• CADISP (Cervical Artery Dissection and Ischemic Stroke Patients) (1)
• CADISS: ASA vs anticoagulation for vertebral artery dissection = (1)
• CAFE (1)
• CALORIES (1)
• CAMELLIA-TIMI 61 (1)
• CAMTAF (1)
• CANALISE 1 (1)
• CANPAP (1)
• CANUSA (1)
• CANVAS ANA CANVA R (1)
• CANVAS AND CANVAS-R FOR CANAGLIFLOZIN (1)
• CANVAS-R AND CANVAS (1)
• CANVAS/CANVAS-R (1)
• CAPSTONE-1 (1)
• CAPTIM (1)
• CARDS (1)
• CARE-HF (1)
• CARESS (1)
• CARESS IN AMI AND TRANSFER-AMI (1)
• CARMEN: Resveratrol in COPD (1)
• CAST (1)
• CAST II (1)
• CAST- ASPIRIN POST CVA (1)
• CASTLE AF (1)
• CASTLE-HF (1)
• CATIS (1)
• CAVENT (1)
• CAVENT AND ATTRACT (1)
• CE MARC (1)
• CENSER (1)
• CERVICAL ARTERY DISSECTION IN STROKE STUDY (1)
• CHAMPION CARDIOMEM (1)
• CHAMPION CARDIOMEMS (1)
• CHAMPION HF (1)
• CHAMPION PIC (1)
• CHAMPS Study= (1)
• CHEETAH (1)
• CHEST (1)
• CHEST 12 (1)
• CHRISTOPHER STUDY (1)
• CIBID-II (1)
• CIBIS & CIBIS II & CHARM-alternative (1)
• CIBIS ) beta blockers (1)
• CIBIS - III (1)
• CIBIS II-- (1)
• CITRIS (1)
• CLARIFY (1)
• CLARINET (1)
• CLARITY TIMI-28 (1)
• CLASP - Low dose aspirin for pre-eclampsia. (1)
• CLASS (1)
• CLEOPATRA= (1)
• CLL11 (1)
• CLOTS 3 (1)
• CLOVER: Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis (1)
• COAPT AND MITRA-FR (1)
• COAT (1)
• COG STUDY (1)
• COLUMBUS (1)
• COLUMBUS IN COPS PATIENTS (1)
• COMBAT (1)
• COMBINED NIVOLUMAB AND IPILIMUMAB OR MONOTHERAPY IN UNTREATED MELANOMA (1)
• COMED (1)
• COMFORT1 (1)
• COMMANDER-HF (1)
• COMPARE-ACUTE (1)
• COMPASS (19) GI (1)
• COMPASS PAD (1)
• COMPASS STUDY (1)
• COMS- COLLABORATIVE OCULAR MELANOMA STUDY (1)
• CONFIRM (1)
• CONQUER (1)
• CONTINUOUS POSITIVE AIRWAY PRESSURE FOR CENTRAL SLEEP APNEA AND HEART FAILURE (1)
• COPD (1)
• COPE (1)
• COPPS (1)
• CORAL (Cardiovascular outcomes in renal atherosclerotic lesions) (1)
• CORAL STUDY FOR RENAL ARTERY STENT VS MEDICAL THERAPY (1)
• CORAL from NEJM 14 (1)
• CORAL study renal artery stenosis (1)
• COREVALUE US PIVOTAL (1)
• COREVALVE US PIVOTAL (1)
• COSMIC-HF (1)
• COSMOS (1)
• CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea. (1)
• CREDENCE (NEJM 19) (1)
• CREDENCE. (1)
• CREEDENCE (1)
• CREOLE (1)
• CRISP AMI (1)
• CRISP for nephrology= (1)
• CROSS 12 NEJM (1)
• CRUSADE. Morphine post MI (1)
• CRYO-ROP (1)
• CRYSTAL AF (cryptogenic stroke and no known a fib - looking at a fib prevale= (1)
• CRYSTAL-AF (1)
• CURRENT-OASIS 7 (1)
• CVD-REAL (1)
• CVLPRT (1)
• Cabana= (1)
• Callisto (1)
• Capstone-1 (baloxavir vs oseltamivir) (1)
• Cardia (1)
• Cardio Mems (1)
• Cardiovascular Risk Reduction by Early Anemia Treatment with Epoetin B (CREA= (1)
• Carpreg I and II (1)
• Catheter ablation of stable ventricular tachycardia before defibrillator Imp= (1)
• Champion (tested CardioMEMS) (1)
• Charm alternative= (1)
• Chemotherapy for oesophageal cancer followed by surgery study (cross) = (1)
• Cibis II (1)
• Cobra 1 and cobra 2 (1)
• Collaborative Corneal Transplant Studies (CCTS) (1)
• Comparison of dopamine and norepinephrine in the treatment of shock. Nejm 3/4/10 (1)
• Competitive effectiveness of vancomycin and metronidazole for prevention of r= (1)
• Complete (1)
• Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in t= (1)
• Crest 2. Dawn (1)
• Current oasis (1)
• D-PRESCRIBE (1)
• DASH diet and risk of subsequent kidney disease.= (1)
• DAWN AND DEFUSE 3 (1)
• DAWN AND DIFFUSE (1)
• DAWN STUDY (1)
• DAWN trail. (1)
• DECIMAL (1)
• DECLARE (1)
• DECLARE-TIMI 58 (1)
• DECLARE-TIMI 65 (1)
• DECOMPRESSIVE CRANIECTOMY IN DIFFUSE TRAUMATIC BRAIN INJURY (1)
• DECRA (1)
• DECREASE-V (1)
• DEFENSE-PFO (1)
• DEFENSE-PRO (1)
• DEFUSE 3 AND DAWN (1)
• DEFUSE STROKE (1)
• DEFUSE. NEJM feb 18 (1)
• DESTINY 1 AND 2 (1)
• DETAIL (1)
• DETAIL ( Diabetics exposed to telmisartan and enalapril (1)
• DETAIL - controlled (1)
• DETAILS (1)
• DETO2X-AMI; NCT01787110 (1)
• DIABOLO (1)
• DIAD (1)
• DIAMOND-MI (1)
• DIGAMI 1 AND 2 (1)
• DIGAMI 1 AND 2 STUDY IN DIABETES (1)
• DINAMIT (1)
• DISCOVER (1)
• DOMINO-AD (1)
• DOVE (1)
• DREAM and /or MENSA (mepolizumab and severe asthma (1)
• DUAL PCI (1)
• DURIE BG (1)
• Daniel A. Rodriguez (1)
• = (1)
• Daratumumab (1)
• Declare (1)
• Declare TIMI 58 (1)
• Declare TIMI-58 (1)
• Declare-Timi (1)
• Defuse and dawn the most recent stroke (1)
• Delirium as a predictor of mortality in mechanically ventilated patients in t= (1)
• DiRECT (1)
• Diet related studies. Fruits and vegetables specifically. (1)
• Diverticulitis/diverticulosis= (1)
• Drip htn and HD pts/ under nephrology (1)
• Dual Antithrombtic Therapy with Davigatran after PCI in Atrial Fibrillation. (1)
• Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a doubl= (1)
• E0=B8=AA=E0=B9=88=E0=B8=87=E0=B8=88=E0=B8=B2=E0=B8=81 iPad =E0=B8=82=E0=B8=AD= (1)
• E0=B8=AA=E0=B9=88=E0=B8=87=E0=B8=88=E0=B8=B2=E0=B8=81 iPhone =E0=B8=82=E0=B8= (1)
• E2=80=8F=E2=80=AB=D9=85=D9=86 =D8=AC=D9=87=D8=A7=D8=B2 =D8=A7=D9=84=D9=80 i= (1)
• E5=8F=91=E8=87=AA=E6=88=91=E7=9A=84iPad= (1)
• E5=BE=9E=E6=88=91=E7=9A=84 iPhone =E5=82=B3=E9=80=81= (1)
• E5=BE=9E=E6=88=91=E7=9A=84iPhone=E5=82=B3=E9=80=81= (1)
• EAGLE (1)
• EAGLES (Evaluating Adverse Events in a Global Smoking Cessation Study) (1)
• EAGLES STUDY - NEUROPSYCHIATRIC SAFETY OF VARENICLINE (1)
• EAGLES study - reviewed incidence of neuropsychiatric side effects among mul= (1)
• EAGLES- SMOKING CESSATION TRAIL (1)
• EBCTCG RT after BCT (1)
• ECLIPSE study: prospective evaluation of COPD longitudinally to if story pre= (1)
• EDEN (1)
• EDITION - LANTUS U300 (1)
• EFFECTS OF ANACETRAPIB IN PATIENTS WITH ATHEROSCLEROTIC VASCULAR DISEASE (1)
• EINSTEIN-DVT (1)
• EKOS (1)
• ELAIN Trail and now the 1 year follow up is available. (1)
• ELIANA (1)
• ELIXA (1)
• ELLDOPA (1)
• EMPA-REG (1)
• EMPIRICUS (1)
• EMPIRICUS RCT FROM JAMA (1)
• EMPOWER (1)
• EMPOWER STUDY ON BENZODIAZEPINE REDUCTION (1)
• ENDURANCE (1)
• ENDURANCE (heartware) (1)
• ENDURANCE VAD (1)
• ENGAGE (1)
• ENGAGE AF TIMI (1)
• ENGAGE AF TIMI 48 (1)
• ENGAGE AF-TIMI (1)
• ENGAGE AF-TIMI48 (1)
• ENGAGE AF. Edoxaban (1)
• ENGAGE TIMI 48 (1)
• ENHANCE (1)
• ENIGMA 2 (1)
• ENIGMA I (1)
• ENOXACAN AND ENOXACAN-II (1)
• ENTRUST (1)
• EOLIA AND CESAR EVALUATING ECMO IN ARDS (1)
• EOLIA. (1)
• EOLIA= (1)
• EPANIC (1)
• EPIDEMIOLOGY (1)
• EPVent and EPVent2 (1)
• ERASE (1)
• ESA APPRISE (1)
• ESPS2 (1)
• ESSENCE STUDY (1)
• EU-PACT (1)
• EUFEST (1)
• EVOLOCUMAB AND CLINICAL OUTCOMES IN PATIENTS WITH CARDIOVASCULAR DISEASE (1)
• EXODUS (1)
• EXPRESS (1)
• EXPRESS STUDY (1)
• EXPULSION THERAPY FOR KIDNEY STONE (1)
• EXTEND (1)
• EXTENDED-RELEASE NALTREXONE TO PREVENT (1)
• Eagles= (1)
• Early goal directed therapy for septic shock =E2=80=94 a patient level meta a= (1)
• Early surgery vs. conventional treatment for infective endocarditis Nejm 1= (1)
• Early vs. Late Parenteral nutrition in critically ill adults (NEJM 11) (1)
• Eden and PermiT (1)
• Edict (1)
• Edoxaban versus Warfarin in Patients with Atrial Fibrillation.= (1)
• Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients W= (1)
• Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response Among Pat= (1)
• Effect of Nesiritide in Patients with Acute Decompensated Heart Failure (1)
• Effect of Patiromer on serum potassium level in patients with hyperkalemia a= (1)
• Effect of aspirin in all cause mortality in the healthy elderly (ASPREE tria= (1)
• Effective of aspirin on all-cause mortality in the healthy elderly (ASPREE) (1)
• Effectiveness of intermittent pneumatic compression in reduction of risk of d= (1)
• Effects of a restricted elimination diet on the behaviour of children with a= (1)
• Effects of tranexamic acid on death (1)
• Efficacy and economic assessment of conventional ventilatory support versus e= (1)
• Efficacy and safety of quetiapine in critically ill patients with delirium (1)
• Einstein Choice published in nejm in March 17 (1)
• Emergency Department Query for Patient-Centered Approaches to Sexual Orienta= (1)
• Empiricus.= (1)
• Endovascular Aneurysm repair and outcome in patients unfit for for open repa= (1)
• Engage-AF TIMI 38. So budding cardiologists can compare all of the available= (1)
• Ensure-AF (1)
• Enviado desde mi iPad (1)
• Envoy=C3=A9 de mon iPhone= (1)
• Euro Lupus (1)
• Europa= (1)
• Evaluation of heparin dosing based on adjusted body weight in obese patient= (1)
• Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular (1)
• Evaluation study of congestive heart failure and pulmonary artery catheteriz= (1)
• Everest Mitra Clip (1)
• Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. FO= (1)
• FACCT (1)
• FASTER (1)
• FEASIBILITY (1)
• FERRIC GLUCONATE IS HIGHLY EFFICACIOUS IN ANEMIC (1)
• FFR FOR LEFT MAIN DZ (1)
• FIELD FENOFIBRATE STUDY (1)
• FINGER STUDY (1)
• FINGER study on Alz (1)
• FISH INTAKE IN PREGNANCY AND CHILD GROWTH ARTICLE IN JAMA (1)
• FIX-HF (1)
• FLAME (1)
• FLAME: QVA149 vs Salmeterol/Fluticasone Combination (NEJM 16) (1)
• FLARE (1)
• FLEX (1)
• FLORALI study. Frat et al. NEJM 15 (1)
• FLORALLY (1)
• FOCUS - Functional Outcomes in Cardiovascular Patients Undergoing Surgical H= (1)
• FOCUS FOR TRANSFUSION (1)
• FOLLOWING (1)
• FRAME (1)
• FRAMINGHAM (1)
• FRAMINGHAM HEART STUDY (1)
• FULFIL Study: Triple Bronchodilator therapy. (1)
• FULFIL= (1)
• FUTIER E (1)
• Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEAT= (1)
• First and second trimester evaluation of risk (FASTER) (1)
• For the Obstetrics Section:= (1)
• GALACTIC-HF (1)
• GALILEO (1)
• GALLIUM (1)
• GAS (1)
• GASTRIC AND ESOPHAGEAL CANCER (1)
• GEMINI 1 AND 2 (1)
• GEMINI STUDY (1)
• GERIKET (1)
• GLAGOV (1)
• GOLD (1)
• GORE REDUCE (1)
• GRAHAM DJ (1)
• GRAVITAS JAMA 11;305:1097-105 (1)
• GREACE (1)
• GUIDE-IT (1)
• GWPCARE4 (1)
• General surgery/trauma/emed= (1)
• HALT PKD (1)
• HALT-MS (1)
• HARMONY 6 (1)
• HARPS (1)
• HART HEART FAILURE ADHERENCE AND RETENTION (1)
• HAS-BLED (1)
• HATS 13 (1)
• HEAAL (1)
• HEART SCORE (1)
• HEARTMATE (1)
• HEAT PPCI TRAIL (1)
• HEAT-PPCI (1)
• HELP (1)
• HELSINKI (1)
• HERCULES (1)
• HF ACTION (1)
• HIGH INTENSITY STATIN STUDY (1)
• HIMALAYA (1)
• HINTS (09) (1)
• HIPARCO (1)
• HISTORIC (1)
• HOKUSAI (1)
• HOKUSAI VTE (1)
• HOPE 2 AND 3 (1)
• HORIZON (Zoledrinic acid for osteoporosis) (1)
• HORIZON-AMI (1)
• HORIZON-HF (1)
• HORIZONS AMI (1)
• HORIZONS-AMI (1)
• HORIZONS-AMI. (1)
• HOT (1)
• HOW ABOUT ADDING THE SOME (1)
• HOWLONG (1)
• HPV FOCAL (1)
• HYPITAT (1)
• Higya study (1)
• Hikoshai vte trail- for apixaban in cancer patient for dvt prophylaxis. (1)
• Hopeful heart (1)
• Hygia Chronotherapy (1)
• Hyperion clinical (1)
• I would love more neurosurgical content. (1)
• I'm a pulmonary fellow (1)
• I-PRESERVE (1)
• IHAST (1)
• ILLUMINATE (1)
• IMPACT (1)
• IMPACT (NEJM. 18;378:1671) (1)
• IMPACT: The Informing the Pathway of COPD Treatment. NEJM (1)
• IMPECT IN TX CMV (1)
• IMPI (1)
• IMPRESS (1)
• IMPRESS IN SEVERE SHOCK (1)
• IMPULSIS 1 AND IMPULSIS 2 (1)
• INFUSE-AMI. (1)
• INHERIT (1)
• INPULSIS (1)
• INSTEAD - comparing TEVAR and medical therapy for type B aortic dissection. (1)
• INSTEAD FOR AORTIC DISSECTION (1)
• INSTINCT COHORT (1)
• INTERACT AND ATACH (Blood pressure in Intracranial Bleeds) (1)
• INTERACT AND ATTACH STUDIES (1)
• INTERACT II (1)
• INTERACT NEUROLOGY BLOOD PRESSURE (1)
• INTERACT1 (1)
• INTERSALT STUDY (1)
• INTERSEPT (1)
• INVIGORATE (1)
• INstead (1)
• ION 1 (1)
• IOTA (Chu et al (1)
• IRMA= (1)
• ISAR-SAFE (1)
• ISIS1 (1)
• ISOTONIC SOLUTIONS AND MAJOR ADVERSE RENAL EVENTS (1)
• ISSUE 3 (1)
• In.Pact DEEP (1)
• Indacaterol/glycopyrronium vs fluticasone/salmeterol for copd (1)
• Initial Trophic vs Full Enteral Feeding in Patients With Acute Lung Injury -= (1)
• Initiation of anti retro viral therapy in early asymptomatic HIV infection= (1)
• Initiation strategies for renal replacement therapy in the intensive care u= (1)
• Inpress (1)
• Intermittent vs continuous proton pump inhibitor therapy for high-risk ble= (1)
• Intramuscular versus antibiotic therapy for the prevention of meningitis an= (1)
• Iowa women=E2=80=99s health study= (1)
• Isar Raact 5 (1)
• Ischemia (1)
• Ischemia= (1)
• JAMA 12 308 1566 (1)
• JELIS (1)
• Jessie Decker Schaumburg (1)
• Jose Ajoc Jr. MD (1)
• June 27 (1)
• KATTAH (1)
• KEEPS (1)
• KEEPS STUDY (1)
• KERSTJENS (1)
• KINDLY ADD (1)
• KINECT: phase 3 (1)
• KRONOS (1)
• Kalyani Kumar (1)
• Kerr (primary author) (1)
• Ketogenic Diet (1)
• LANDMARK PARTNER (1)
• LANTERN (1)
• LAPLACE-2 (1)
• LAPS (1)
• LEADLESS (1)
• LEGACY trail (1)
• LEOPARDS (1)
• LEUVEN MEDICAL (1)
• LEVO-REP (1)
• LEVOSIMENDAN (1)
• LIDO (1)
• LIDOKET RCT 18 (1)
• LIFE (1)
• LIPID STUDY (1)
• LIRAGLUTIDE AND RENAL OUTCOMES IN TYPE 2 DIABETES (1)
• LOFT (1)
• LOV-ED (1)
• LUMINA (1)
• LUNAR (1)
• LUNG OPEN VENTILATION (1)
• Linagliptin vs Glimperide and Cardiovascular Outcomes in Patients with Type 2= (1)
• Longitudinal Assessment of Bariatric Surgery (LABS) (1)
• MACE (1)
• MADIT (1)
• MADIT-RIT (1)
• MAGPIE (1)
• MAGPIE (02 lancet) (1)
• MAINTAIN NEPHRITIS (1)
• MANAGE Lancet 18 (Deveraux et al) (1)
• MARCANTONIO (1)
• MARE (1)
• MARISA (1)
• MARRIED (1)
• MASTER (1)
• MASTERS (1)
• MELD SCORE (1)
• MENDS from 07 (1)
• MENDS= (1)
• MEPOLIZUMAB FOR EOSINOPHILIC CHRONIC OBSTRUCTIVE PULMONARY DISEASE (1)
• MERIN TIMI36 (1)
• MERLIN (1)
• MET-REMODEL (1)
• MIAMI (beta blockers) (1)
• MIDAS (1)
• MIG (1)
• MIST 1 AND 2 (1)
• MIST 2 (1)
• MIST II (1)
• MIST- tpa and DNase in pleural fluid. (1)
• MIST-1 (1)
• MIST1 & MIST2 (1)
• MITRA-FR: percutaneous repair with the mitral clip device for severe seconda= (1)
• MITY (1)
• MLST2 (1)
• MOCHA (1)
• MOMEMTUM 3 (1)
• MOMENTUM HEART MATE 3 (1)
• MORDOR (1)
• MORE IBD (1)
• MOST (1)
• MR CLEAN (NEJM 15) (1)
• MR-CLEAN : N Engl J Med 15;372:11-20. (1)
• MSLT-1 AND MLST-2 (1)
• MSLT-2 (1)
• MSLT-I and MSLT-II (1)
• MSLT-I and MSLT-II RCTs which address/discuss utility of sentinel lymph node= (1)
• MSLT1 AND MSLT2 FOR MELANOMA (1)
• MSLT1 and MSLT2 (1)
• MUSIC (1)
• MYLES P (1)
• Magic for gastric cancer.= (1)
• Mdrd study. Modification of diet in renal disease. (1)
• Mepopizumab or placebo for EGPA (1)
• Metformin in Gestational Diabetes: the offspring follow-up (MiG TOFU) study (1)
• Mitra fr (1)
• Mitra-FR (1)
• Mosaic. (1)
• Mr clean for endovascular treatment of ischemic stroke. There are 5 main tr= (1)
• Myburgh J. Hydroxyethyl starch or saline for fluid resuscitation in intensi= (1)
• N Engl J Med 09;360:2165-75 (1)
• NACSTOP (1)
• NAGIVATE ESUS (1)
• NEED TO GET THE AWESOME (1)
• NEXUS C SPINE (1)
• NICE SUGAR (1)
• NOBLE (CABG VS PCI) (1)
• NOBLE. (1)
• NON CONTRAST CT FOR KIDNEY STONES (1)
• NORDIC (1)
• NORSWITCH and VARSITY (1)
• NSABP B04 (1)
• NUTRIREA2 (1)
• Nadyeschka Rivera MD (1)
• Narcotic= (1)
• Ninetinib in ILD and (1)
• Nivolumab versus Docetaxel in advanced squamous-cell Non-small-cell lung c= (1)
• OAC alone circ (1)
• OASIS-5 FONDAPARINUX VS ENOXAPARIN IN ACUTE CORONARY SYNDROMES (1)
• OAT - IMPORTANT (1)
• OCCLUDED ARTERY (1)
• ODYSSEY (1)
• ODYSSEY OUTCOMES (1)
• OFF-PUMP VS ON-PUMP CABG (1)
• OMEPRAZOLE BEFORE ENDOSCOPY IN UGIB (1)
• OMERACT 9 (1)
• ONT (1)
• ONYX ONE (1)
• OPTALYSE (1)
• OPTALYSE PE (1)
• OPTIDUAL (1)
• OPTIMAL Study. (Canadian) (1)
• OPTIME (1)
• OPTIME-CHF STUDY (1)
• OPTIMIZE-HF STUDY (1)
• ORAL VANCOMYCIN FOR SECONDARY PROPHYLAXIS OF CLOSTRIDIUM DIFFICILEINFECTION (1)
• ORIGINAL ARTICLE (1)
• OSLER (1)
• OSLER 1 (1)
• OTPE (1)
• OVIDA. Oral vs IV antibiotics in osteomyelitis. (1)
• Omadacycline for Bacterial Pneumonia (1)
• Once-Weekly Dalbavancin versus Daily Conventional Therapyfor Skin InfectionH= (1)
• Optimise 1= (1)
• Original Framingham (1)
• Oscar (1)
• Ouriel= (1)
• PABA CHF (1)
• PAC-MAN (1)
• PACE - PARACETAMOL FOR LOW-BACK PAIN STUDY (1)
• PACIFIC (1)
• PADIS (1)
• PADIS-PE (1)
• PALOMA (1)
• PANTHER-IPF (1)
• PAPABEAR (1)
• PARAGON HF (1)
• PARAMEDIC-2 (1)
• PARAMOUNT HEART FAILURE (1)
• PARR2 (1)
• PARROT (1)
• PARTAGE study published in JAMA June 15 (1)
• PARTIAL ORAL VERSUS INTRAVENOUS ANTIBIOTIC TREATMENT OF ENDOCARDITIS (1)
• PARTNER AND PARTNER 2 (1)
• PARTNER II (1)
• PATCH 3 (1)
• PATCH PLATELETS FOR ICH (1)
• PATHOS & INSPIRE= (1)
• PATHWAY 2 (1)
• PATHWAY-2 Lancet= (1)
• PATHWAYS 2 (1)
• PATO (1)
• PATRICIA : HPV vaccine (1)
• PEACE (1)
• PEACH (1)
• PECARN DKA fluid infusion (1)
• PECARN STUDY (1)
• PEEP TRAIL (1)
• PEGASUS TIMI (1)
• PEGASUS-TIMI 54 (1)
• PELVIS (1)
• PEMBROLIZUMAB VERSUS DOCETAXEL FOR PREVIOUSLY TREATED (1)
• PERC (1)
• PERIOP 2 (1)
• PERISCOPE (1)
• PERMIT (1)
• PEXIVUS (1)
• PHASE 3 APEX STUDY (1)
• PHLEBOTOMY FOR POLYCYTHEMIA VERA (1)
• PIETHO (1)
• PIONEER AF (1)
• PIONEER HF (1)
• PIONEER-AF (1)
• PIVENS study. Pioglitazone versus Vitamin E versus Placebo (1)
• PIVOTAL (1)
• PLATFORM (1)
• PLCO FOR PROSTATE CANCER SCREENING (1)
• PLCO PROSTATE (1)
• PLOS ONE (1)
• POLAR-RCT (1)
• PONTIAC (1)
• POP UP (1)
• PORTICO (1)
• POSEIDON (1)
• PRAISE (prospective amlodipine survival evaluation). Also PRAISE= (1)
• PRAISE -2 (1)
• PRECISION (cardiovascular safety of celecoxib (1)
• PRECOMBAT. (1)
• PRECOMBAT= (1)
• PREDESCI (1)
• PREDIAN (1)
• PREEMPT (1)
• PREEMPT studies 1 and 2. OnabotulinumtoxinA treatment for chronic migraine (1)
• PREFER (1)
• PRESTO (1)
• PREVAIL (1)
• PRIME IN COLORECRAL CANCER (1)
• PRINCIPAL RESULTS OF THE JAPANESE (1)
• PRISM in NEJM 17. (1)
• PRISM-- early goalndirected therapy for septic shock-- a patient level meta= (1)
• PRISMS TRAIL (1)
• PROACT published in JACC june 18 (1)
• PROGRESS (1)
• PROGRESS AND WARSS (1)
• PROLONG AND PROLONG-II (1)
• PROMMTT (1)
• PROMPT (1)
• PRONING IN REFRACTORY HYPOXEMIA IMPROVES SURVIVAL (1)
• PROPAC. (1)
• PROPER 18 (1)
• PROPPER (1)
• PROSPE (1)
• PROSTATE (1)
• PROTECT (1)
• PROUD PREP STUDY (1)
• PROUD: pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (1)
• PROVIDE (1)
• PROXI AND AVOID (1)
• PURE-STUDY (1)
• PURSUIT (1)
• Pace (1)
• Paclitaxel-Carboplatin Alone or with Bevacizumab for non-Small-Cell Lung Can= (1)
• Panther (1)
• Paragon (1)
• Paragon HF (1)
• Paragon-hf (1)
• Paramount (entresto in hfpef) (1)
• Parkinson's disease seminal (1)
• Pause (1)
• Pegasus TIMI 54. (1)
• Pegasus timi 54 - long term use of ticagrelor in pts w/ mi (1)
• Perioperative normothermia to reduce the incidence of surgical-wound infecti= (1)
• Perner a. Nejm 12;367:124-34 (1)
• Pethema (1)
• Please we need more rheumatology (1)
• Polar clinical (1)
• Post-Operative Radiation Therapy in Endometrial Cancer (PORTEC)= (1)
• Prednisone for the prevention of Paradoxical TB IRIS : PredArt (1)
• Preserve - nejm 18 (1)
• ProACT: procalcitonin antibiotic consensus (1)
• Proactive: pioglitazone (1)
• Prospective Evaluation of Celecoxib Integrated Safety versus Ibup= (1)
• Protect and prevail for watchman. (1)
• Protect-AF. Watchman in LAA (1)
• Pulmonary (1)
• QUALIFY (1)
• QUALIFY STUDY (1)
• QUARTZ (1)
• RABBIT (1)
• RABBIT2. (1)
• RADIANCE (1)
• RAFT-AF (1)
• RAID (1)
• RAISE (1)
• RAPCO (1)
• RATIFY ALLIANCE (1)
• RE-DUEL (1)
• REACT (1)
• REACT study= (1)
• REACT-2 (1)
• REAL-CAD (1)
• RECAST (1)
• RECENT (1)
• RECENTLY CAME OUT (1)
• RECORD (1)
• RECORD3 (1)
• RECOVER (1)
• RECOVER-RIGHT (1)
• REDEEM (1)
• REDUAL (1)
• REDUCE IT TIRAL NCT01492361 (1)
• REDUCE MRSA (1)
• REDUCE-MRSA (13) (1)
• REGISTRO ADHERE (1)
• RELAX-AHF (1)
• REMATCH STUDY (1)
• RENAL-AF (1)
• REPRISE (1)
• RESCUE-ICP (1)
• RESOLV (1)
• RESONATE-2 (1)
• RESTART (1)
• REVEAL PULMONARY HYPERTENSION STUDY (1)
• REVEAL. DOI: 10.1056/NEJMoa1706444. (1)
• REVERSE AD (1)
• REVISE (1)
• RIDDLE- NSTEMI (1)
• RIFLE-STEACS (1)
• RIM (rituximab in myositis) (1)
• RITA-3 (1)
• RITUXIMAB VS CYCLOPHOSPHAMIDE IN ANCA-ASSOCIATED RENAL VASCULITIS (1)
• RITUXVAS (1)
• RIVUR (1)
• ROBBY (1)
• ROMICAT I AND II (1)
• ROOBY (1)
• ROSE STUDY (1)
• RTOG 0234 (1)
• Rabbit2. It is not showing up in the app but is on the wiki.= (1)
• Rapid measurement of bnp ("breathing not properly" (1)
• Re-CIRCUIT= (1)
• Re-spect cvt (1)
• ReHOT - 18 Spironolactone vs Clonidine as a Fourth-Drug Therapy for Resi= (1)
• Recover and Recover II (1)
• Reduce-it from NEJM (1)
• Reevaluation of Systemic Early Neuromuscular Blockade (ROSE) (1)
• Regarding treatment for pediatric bronchiolitis: (1)
• Resolute (1)
• Respectfully (1)
• Restart (1)
• Reverse Flow Used During Carotid Artery Stenting Procedure (ROADSTER) multic= (1)
• Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy (1)
• Romosozumab treatment in postmenopausal women with osteoporosis. Cosman F (1)
• SAFE-A (1)
• SAGE (1)
• SAINT I AND II (1)
• SAMPRISS (1)
• SAPHIRS (1)
• SAPIT (1)
• SAVOR TIMI 53 (1)
• SAVOR-TIMI (1)
• SAVOR-TIMI 53 (1)
• SCOT-HEART (1)
• SCOT-HEART= (1)
• SEATLLE II (1)
• SEATTLE (1)
• SELECT (1)
• SELECT D (1)
• SENECA (1)
• SENIOR (1)
• SEPSIS 3 (1)
• SEPSIS 3 BY JAMA (1)
• SHARP- Studies of heart and renal protection. Baigent et al. The Lancet. 1= (1)
• SHARP- Study of Heart And Renal Protection showed a 17% reduction in major a= (1)
• SHARP. STUDY of heart and renal protection. (1)
• SHEP (1)
• SHEP - SYSTOLIC HYPERTENSION IN THE ELDERLY (1)
• SHIELD (1)
• SHIELD re Cobra aren=E2=80=99t (1)
• SHIFT (Ivabradine in HFrEF) (1)
• SHINE (1)
• SHaRP - the study of heart and renal protection ... probably in nephrology m= (1)
• SIMPLE (1)
• SMART DATE (1)
• SMART-CHOICE (1)
• SOCRATES - thanks! (1)
• SOLITAIRE-IV AND SOLITAIRE-ORAL (1)
• SOME STUDY (1)
• SONAR (1)
• SOX (1)
• SPACE STUDY (1)
• SPARK (1)
• SPICE 3 (1)
• SPLINT (1)
• SPLIT Clinical (1)
• SPLIT double-crossover (1)
• SPLIT - ICU (1)
• SPLIT STUDY (1)
• SPOCC-TRIAL (1)
• SPORT (spine patient outcome research (1)
• SPRINT NEJM (1)
• SPRINT: Intensive versus Standard Blood-pressure Control (1)
• STABLE (1)
• STAMINA (1)
• STAREE (1)
• START (1)
• STELVIO (1)
• STENO-2 (1)
• STEP-BD (1)
• STICHES. (1)
• STLLR (1)
• STOP (1)
• STOP-DAPT and Smart-Choice (1)
• STOP-DAPT2= (1)
• STOP2 (1)
• STOPDAPT (1)
• STOPIT (1)
• STORM (1)
• STREAM - NJEM(13) (1)
• SUBMIT-APP (1)
• SUGAMMADEX (1)
• SURGICAL TREATMENT OF SEVERE ISCHEMIC MITRAL REGURGITATION (1)
• SUSTAIN 6 (1)
• SWITCH (1)
• SWITCH 1 (1)
• SWORD (1)
• SYDNEY (1)
• SYMPLICITY (1)
• SYNTHESIS PILOT (1)
• SYSTOLIC BLOOD PRESSURE INTERVENTION (1)
• Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab ve= (1)
• Samantha (1)
• Selective serotonin reuptake inhibitors versus placebo in patients with majo= (1)
• Sj=C3=B6str=C3=B6m L: Review of the key results from the Swedish Obese Subje= (1)
• Sleep heart health study= (1)
• Small bites vs large bites for closure of abdominal midline incisions: doub= (1)
• Stable dosages of clobazam for Lennox-gustaut syndrome are associated with= (1)
• Steroids or pentoxifylline for alcoholic hepatitis (STOPAH (1)
• Stopdapt 1&2 (1)
• Stott DJ (1)
• Studies on use of anti- TNF agents in IBD. (1)
• Study of the effects of nebivolol intervention on outcomes and rehospitaliza= (1)
• Switch 1 and 2 (1)
• Sygma 1 (1)
• T-trial (testosterone supplementation). (1)
• TABLET (1)
• TAILORX (1)
• TAPS STUDY (1)
• TARDIS (1)
• TARGET (1)
• TEAAM (1)
• TECOS (1)
• TECOS: Jul 15 (1)
• TEMPRANO (1)
• TENOR (1)
• TEOSS Findling et al 10.=20 (1)
• TEXT: tamoxifen and exemustane (1)
• THE ACUTE (1)
• THE ATLAS (1)
• THE AUGUSTUS (1)
• THE COAT (1)
• THE DAWN (1)
• THE EAGLES (1)
• THE ECLIPSE STUDY (1)
• THE FOCUS (1)
• THE HEMO (1)
• THE HYPERGLYCEMIA AND ADVERSE PREGNANCY OUTCOME STUDY (1)
• THE IMPI (1)
• THE LONG-TERM OXYGEN TREATMENT (1)
• THE MATRIX (1)
• THE NEW EASTR STUDY OUT OF THE UK (1)
• THE OPTIC NEURITIS TREATMENT (1)
• THE PROPER (1)
• THE PROPPR (1)
• THE RESET (1)
• THE REVERT (1)
• THE ROTTERDAM STUDY (1)
• THE SAPPHIRE (1)
• THE SEATTLE 2 (1)
• THE SPRINT (1)
• THE STOPAH (1)
• THE TERM BREECH (1)
• THE ULTIMA (1)
• THE YEARS STUDY (1)
• THERAPEUTIC HYPOTHERMIA IN ORGAN DECEASED DONORS AND DELAYED GRAFT FUNCTION (1)
• THERMAL STABILITY OF THE PREMATURE INFANT IN NEONATAL INTENSIVE CARE (1)
• THINKER= (1)
• TIME 2 (1)
• TITAN- CAPLACIZUMAB FOR TTP (1)
• TOAST (1)
• TODAY (1)
• TOGA (1)
• TORIC= (1)
• TOTAL (1)
• TRACER study. (1)
• TRACMAN (1)
• TRACMAN - ICU TRACHE (1)
• TRAFFIC (1)
• TRAFFIC/TRANSPORT (1)
• TRANSFer AMI (1)
• TRAPID-AMI (1)
• TREAT-TO-TARGET (1)
• TRED- HF (1)
• TRIBUTE and IMPACT (1)
• TRICS (1)
• TRIIM (1)
• TRILOGY (1)
• TRILOGY ACS= (1)
• TRILOGY-ACS (1)
• TRILOGY= (1)
• TRINITY (1)
• TRIPICU (1)
• TROPHY; PHARAO= (1)
• TRUST (1)
• TRUST study (1)
• TWILIGHT (1)
• Temkin et al (1990) in NEJM. A (1)
• Tempo 3:4 (1)
• Terisa the ranexa (1)
• Test 1.8 (1)
• Thanks != (1)
• The ANDROMEDA-SHOCK Control (1)
• The ELAIN clinic (1)
• The Emprise (1)
• The LOTT (1)
• The MTA at 8 Years: Prospective Follow-Up of Children Treated for Combined T= (1)
• The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for= (1)
• The STOP IT (1)
• The Switch 1 & 2 study (1)
• The topic of NSTEMI under cardiology is not represented in this app. Here ar= (1)
• Thyroid Hormone Replacement for Untreated Older Adults with Subclinical Hypo= (1)
• Trail Culprit. (1)
• Transfer-MI= (1)
• Treatment for Adolescents with Depression Study (TADS) (1)
• Trial : (1)
• Trial of Anifrolumab in Active Systemic Lupus Erythematosus (1)
• Trial of Cannabidiol for Drug-Resistance Seizures in the Dravet Syndrome.= (1)
• Trilogy ACS (1)
• Twilight Study on asprin. (1)
• U.K. Controlled (1)
• UMPIRE (1)
• Use of the Alberta Stroke Program Early CT Score (ASPECTS) for Assessing CT S= (1)
• V-HEFT II STUDY (1)
• VAPrapid2 (1)
• VELOUR ATRIAL (1)
• VERITAS (1)
• VHEFT-1 ( hydralazine with nitrates ) (1)
• VITAL study (vit D and omega A-3 (1)
• Varsity (1)
• Vasopressin versus Norepinephrine in Patients with Vasoplegic Shock after Ca= (1)
• Vasst= (1)
• Venous Thromboembolism Risk in Ischemic Stroke Patients Receiving Extende= (1)
• Visep: brunkhorst nejm 08;358:125-39 (1)
• WA (1)
• WARRS (1)
• WARSS (1)
• WASH (1)
• WASID AND SAMPRIS (1)
• WEARIT-II (1)
• WOMAN (world maternal antifibrinolytic (1)
• WOMAN: reducing maternal deaths with transexamic acid. Lancet (1)
• Wake up (1)
• Warfarin Aspirin Recurrent Stroke Study (WARRS) (1)
• Watchman device vs warfarin) (1)
• Win Kulvichit (1)
• XANTUS (1)
• XPORT (1)
• YUNOS JAMA 13 (1)
• You guys gave FAME and FAME 2. FAME 3 came out a while back now. ... it=E2=80= (1)
• ZEPHYR (1)
• _003_E5169AC797304C9FBE79E928C405F812myularkinorg_ (1)
• ambition; about PAH (1)
• ambition= (1)
• angiotensin-neprilysin inhibition versus enalapril in heart failure. Thank= (1)
• coact (nejm March 19) coronary angiography in nonstemi cardiac arrest=20= (1)
• credence study (1)
• daptogliflozin and cardiovascular outcomes in type 2 diabetes (DECLARE-TIM= (1)
• declare (1)
• destiny and destiny II. (1)
• f (1)
• global leaders (1)
• [[2]] (1)
• [[3]] (1)
• [[4]] (1)
• [[5]] (1)
• [[6]] (1)
• [[7]] (1)
• [[8]] (1)
• [[9]] (1)
• [[10]] (1)
• [[11]] (1)
• [[12]] (1)
• [[13]] (1)
• [[14]] (1)
• [[15]] (1)
• [[16]] (1)
• [[17]] (1)
• [[18]] (1)
• [[19]] (1)
• [[20]] (1)
• [[21]] (1)
• [[22]] (1)
• [[23]] (1)
• [[24]] (1)
• [[25]] (1)
• [[26]] (1)
• [[27]] (1)
• [[28]] (1)
• m (1)
• nej 009 (1)
• pathway 2= (1)
• pioneer AF.= (1)
• precision= (1)
• selexipag in pulmonary Hypertension ( GRIPHON CLINICAL (1)
• sprint= (1)
• standard vs longer interval Zoledronic Acid Dosing for bone metastases. (1)
• stopah= (1)
• sygma= (1)
• the Study of Ascending Levels of Tolvaptan in Hyponatremia (the SALT (1)
• the effects of vaping on lung health= (1)